• Solutions
  • Technology
  • Industries
  • About Us
  • Blog
  • Resources
  • Get in touch
  • Utilizing Brazil´s New IP System for Pharma and Academics to Optimize Innovation

    Explore how the IP landscape in Brazil is changing and how this affects academia and the pharmaceutical business in our webinar. Learn about fresh prospects for technology transfer, market access, and patent protection brought about by recent legislation. Universities, research facilities, and pharmaceutical businesses looking to increase their capacity for innovation in this fast-growing market should not miss this event.

    Let's talk

    Connect with our experts to discuss your specific needs.

    Interested in joining our team?
    Visit our Work with Us section

    Basic data protection information - Pursuant to the GDPR, SEPROTEC TRADUCCIÓN E INTERPRETACIÓN, S.L.U. shall process the data provided for the purpose of managing existing recruitment processes and enabling you to take part therein. Where applicable, your personal data will be sent to other companies belonging to Seprotec Multilingual Solutions. You can optionally exercise your rights of access, rectification, erasure and any others acknowledged in the aforementioned regulations. For further information on how we process your data, see our privacy policy.


    *Required fields

    Frequently Asked Questions About Innovation and IP in Brazil

    • How is Brazil's IP system changing for the pharmaceutical industry?

      Brazil has reformed its patent examination processes, adopted international cooperation tools and introduced regulatory linkage, affecting drug approval and IP strategy for pharma companies.

    • What opportunities exist for pharma companies in Brazil's IP system?

      Companies can leverage the Patent Prosecution Highway (PPH), accelerated examination tracks and biotech-specific provisions to reduce time to market.

    • How can academics commercialize IP in Brazil?

      Brazil's Innovation Law enables technology transfer offices (NITs) at universities to license patents, create spin-offs and partner with private sector entities.

    • Who should watch this webinar?

      Pharmaceutical companies, biotech researchers, university technology transfer offices and IP attorneys with interests in the Brazilian market.

    +
    Get started

    Thank you for reaching out to Seprotec!

    We have received your request for more ingenerication or a quote, and a member of our team will be in touch shortly. We appreciate your interest in our services and are here to help you Connect, Transmit, and Protect your content with global impact. In the meantime, feel free to contact your nearest Seprotec office. for any immediate needs.

    We look forward to assisting you!